New RAD202 data confirms positive tumor uptake
Radiopharm Theranostics (RAD:AU) has announced New RAD202 data confirms positive tumor uptake Download the PDF here. This post appeared first...
Radiopharm Theranostics (RAD:AU) has announced New RAD202 data confirms positive tumor uptake Download the PDF here. This post appeared first...
Astral Resources NL (ASX: AAR) (Astral or the Company) refers to its off market takeover bid to acquire all of...
Goldman Sachs Kostin analyst has issued a warning that the S&P 500 may be headed for a significant correction. His...
Flagging global sales and Elon Musk’s increasingly outspoken political activities are combining to rock the value of Tesla. Shares in...
DULUTH, Ga. — Former Fox News host Tucker Carlson warmed up the crowd at Donald Trump’s rally here Wednesday night...
“And there’s very few states that benefit like you do from fracking. I mean, you have 500,000 jobs.” — Former...
CLACKAMAS COUNTY, Ore. — In a close contest that could determine control of the House of Representatives, a Republican incumbent...
Several people who once occupied the White House are now energetically crisscrossing the country on behalf of Vice President Kamala...
Donald Trump and other GOP candidates are increasingly targeting transgender people in the election’s closing days, invoking them as boogeymen...
Donald Trump went viral with a carefully staged photo op at McDonalds, an apparent meditation about a golfing legend’s genitalia...
Disclaimer: americanfinancestar.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.